View of Enrichment of intestinal bifidobacterium genus is associated with residual disease among patients with early-stage HER2+ breast cancer (BC) following neoadjuvant chemotherapy (NACT)

Return to Article Details Enrichment of intestinal bifidobacterium genus is associated with residual disease among patients with early-stage HER2+ breast cancer (BC) following neoadjuvant chemotherapy (NACT) Download Download PDF